Biogen's Alzheimer's drug slows mental decline in early study

March 20, 2015 2:05 PM

3 0

(Reuters) - An experimental drug from Biogen Idec became the first Alzheimer's treatment to significantly slow cognitive decline and reduce what is believed to be brain-destroying plaque in patients with early and mild forms of the disease, according to a small study likely to reignite hopes of a treatment.

Alzheimer's is expected to strike as many as 75 million people worldwide by 2030 without effective treatments, likely costing billions of dollars year in care. A successful treatment would pay some of the richest rewards in medicine.

Also read: Apple tells feds ‘new entrants’ to auto industry should get same testing rights as incumbents

Read more

To category page

Loading...